Erlotinib(Tarceva)

Another Name厄洛替尼,LuciErlo,Tarceva

IndicationsIt is mainly indicated for the treatment of metastatic non-small cell lung cancer (NSCLC) harboring specific gene mutations (EGFR exon 19 deletion or exon 21 L858R substitution mutation), as well as f